clarithromycin has been researched along with Lung Diseases, Obstructive in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Freudenstein, J; Hauke, W; Henneicke-Von Zepelin, HH; Köhler, G | 1 |
| Dubois, J; Fong, IW; Grossman, R; Laforge, J; Small, D; Zakhari, R | 1 |
| Brunner, F; Drewe, J; Haefeli, WE; Kaeser, YA | 1 |
| Hill, SL; Johnson, MM; Piddock, LJ | 1 |
| Ishikawa, M; Majima, Y; Nakase, K; Sugawara, Y | 1 |
2 trial(s) available for clarithromycin and Lung Diseases, Obstructive
| Article | Year |
|---|---|
Esberitox N as supportive therapy when providing standard antibiotic treatment in subjects with a severe bacterial infection (acute exacerbation of chronic bronchitis). A multicentric, prospective, double-blind, placebo-controlled study.
Topics: Adjuvants, Immunologic; Adult; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Bronchitis, Chronic; Chronic Disease; Clarithromycin; Double-Blind Method; Drug Therapy, Combination; Humans; Lung Diseases, Obstructive; Pilot Projects; Plant Extracts; Roxithromycin; Time Factors | 2002 |
Clarithromycin versus cefaclor in lower respiratory tract infections. The Canadian Bronchitis Study Group.
Topics: Bronchitis; Cefaclor; Clarithromycin; Female; Haemophilus influenzae; Humans; Lung Diseases, Obstructive; Male; Middle Aged; Pneumonia; Streptococcus pneumoniae | 1995 |
3 other study(ies) available for clarithromycin and Lung Diseases, Obstructive
| Article | Year |
|---|---|
Severe hypotension and bradycardia associated with verapamil and clarithromycin.
Topics: Anti-Arrhythmia Agents; Anti-Bacterial Agents; Bradycardia; Clarithromycin; Drug Interactions; Female; Humans; Hypotension; Lung Diseases, Obstructive; Middle Aged; Ventricular Fibrillation; Verapamil | 1998 |
Effect of carbon dioxide on testing of susceptibilities of respiratory tract pathogens to macrolide and azalide antimicrobial agents.
Topics: Anti-Bacterial Agents; Azithromycin; Carbon Dioxide; Clarithromycin; Colony Count, Microbial; Erythromycin; Haemophilus Infections; Haemophilus influenzae; Humans; Hydrogen-Ion Concentration; Lung Diseases, Obstructive; Microbial Sensitivity Tests; Moraxella catarrhalis; Neisseriaceae Infections; Pneumococcal Infections; Sputum; Streptococcus pneumoniae | 1999 |
[Effect of macrolides on rat models of airway hypersecretion].
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Depression, Chemical; Disease Models, Animal; Lung Diseases, Obstructive; Male; Rats; Rats, Inbred F344; Respiratory Mucosa; Sputum | 2001 |